George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and […]
Read More
On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of George Clinical – CRO China as our guest contributor. With more than 20 years of experience in pharmaceutical, biotech and medical device marketing, Mr. Gregory has spent over 14 years supporting the […]
Read More
After careful selection and consideration, George Clinical’s (GC) Evon Hui of the Hong Kong office has accepted the position of Associate Director, Business Operations, East Asia (EA) and will be reporting directly to Marisa Petersen, Chief Executive Officer of GC. Evon joined GC in November 2012 as the Regional Clinical Operations Manager (COM) for the […]
Read More
New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country
Read More
George Clinical East Asia is headquartered in Hong Kong. From this location, we oversee our on the ground operations in Hong Kong, Taiwan and Malaysia; whilst enabling coverage of other South East Asian countries such as Singapore and Philippines. Office Locations: Units 4305-06, Tower 1, Metroplaza, 233 Hing Fong Road, Kwai Fong, New Territories […]
Read More
